Publications by authors named "S Mizoue"
Article Synopsis
- The study evaluated the effectiveness and safety of selective laser trabeculoplasty (SLT) as both a first-line and second-line treatment for normal-tension glaucoma (NTG) in Japanese patients.
- 99 patients were treated with SLT, showing significant reductions in intraocular pressure (IOP) after one year, with the first-line group demonstrating a higher success rate than the second-line group.
- Most complications observed were minor and temporary, indicating that SLT is a reliable treatment option for NTG regardless of its line of use.
Purpose: To examine primary open-angle glaucoma patients after undergoing combined cataract surgery with microhook ab interno trabeculotomy (μLOT-Phaco) or iStent inject W implantation (iStent-Phaco), and then evaluate the surgical outcomes after a minimum of 6 months of follow-up.
Methods: Between October 2020 and July 2022, 39 μLOT-Phaco eyes and 55 iStent-Phaco eyes that underwent surgery were evaluated in this retrospective, multicenter comparative case series. Data that included preoperative and postoperative intraocular pressure (IOP), number of glaucoma medications, and occurrence of complications were collected from medical records and then examined.
Purpose: A brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination (BBFC) was recently approved for glaucoma and ocular hypertension treatment in Japan. We investigated the efficacy and safety of BBFC used concomitantly with prostaglandin analogs (PG) or a PG/beta-blocker fixed-dose combination (PG/beta FC).
View Article and Find Full Text PDFPurpose: To elucidate the noninferiority of ab interno microhook trabeculotomy (μTLO) using a recently developed reusable stainless spatula-type microhook device to incise the trabecular meshwork to Trabectome (Neomeix, Inc) surgery in terms of the 1-year postoperative outcomes of Japanese patients with glaucoma by means of propensity score analyses.
Design: Multicenter, retrospective cohort study.
Participants: We enrolled 553 and 392 patients who underwent Trabectome surgery and μTLO, respectively, between January 2014 and March 2020 at 10 facilities.